Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
ACEPROMAZINE (AS ACEPROMAZINE MALEATE BP (VET))
Animalcare Limited
QN05AA04
ACEPROMAZINE (AS ACEPROMAZINE MALEATE BP (VET))
2 Mg/Ml
Solution for Injection
VPO-Vet.Practitioner Only
Canine, Feline
Acepromazine
Neurological Preparations
Authorised
2016-07-15
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Acecare 2 mg/ml Solution for Injection for Dogs and Cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution contains ACTIVE SUBSTANCE: Acepromazine 2 mg (as acepromazine maleate 2.71 mg) EXCIPIENTS: Phenol (as preservative) 3 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Injection. Pale yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and Cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Anaesthetic Premedication: Following acepromazine administration, the amount of anaesthetic necessary to induce anaesthesia is considerably reduced. This reduction is approximately one-third of a suitable induction agent. Tranquilisation: Acepromazine tranquilisation (ataraxy) involves a modification of temperament which is not associated with hypnosis, narcosis or marked sedation. This is achieved with low doses of acepromazine. Sedation: At higher dose rates acepromazine is a sedative. 4.3 CONTRAINDICATIONS Do not use in pregnant animals. Do not use on a long term basis in individual animals. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 15/07/2016_ _CRN 7021369_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Acepromazine is hypotensive. Particular care should therefore be taken in hypovolaemic animals; rehydration should precede acepromazine administration. In some dogs, particularly Boxers and other short-nosed breeds, spontaneous fainting or syncope may occur due to sinoatrial block caused by excessive vagal tone. An attack may be precipitated by an injection of acepro Lire le document complet